The Effects of Aldosterone Antagonists in Patients With Resistant Hypertension: A Meta-Analysis of Randomized and Nonrandomized Studies

Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus

(2013) Christina S. Oxlund et al.   JOURNAL OF HYPERTENSION

Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients

(2012) Stacie L. Daugherty et al.   CIRCULATION

Spironolactone treatment in patients with diabetic microalbuminuria and resistant hypertension

(2012) Sunil Kumar Kota et al.   International Journal of Diabetes in Developing Countries

Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT)

(2011) Jan Václavík et al.   HYPERTENSION

Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease

(2011) R Pisoni et al.   JOURNAL OF HUMAN HYPERTENSION

Uso de espironolactona o doxazosina en pacientes con hipertensión arterial refractaria

(2011) Enrique Rodilla et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Rapid Reversal of Left Ventricular Hypertrophy and Intracardiac Volume Overload in Patients With Resistant Hypertension and Hyperaldosteronism

(2010) Krishna Gaddam et al.   HYPERTENSION

Management of resistant arterial hypertension: role of spironolactone versus double blockade of the renin–angiotensin–aldosterone system

(2010) Beatriz Alvarez-Alvarez et al.   JOURNAL OF HYPERTENSION

The effect of low-dose spironolactone on resistant hypertension

(2010) Mette Engbaek et al.   Journal of the American Society of Hypertension

Predictors of Hyperkalemia Risk following Hypertension Control with Aldosterone Blockade

(2009) Nitin Khosla et al.   AMERICAN JOURNAL OF NEPHROLOGY

Efficacy of Spironolactone Therapy in Patients With True Resistant Hypertension

(2009) Fabio de Souza et al.   HYPERTENSION

Hypertension: Reflections on Risks and Prognostication

(2009) William B. Kannel   MEDICAL CLINICS OF NORTH AMERICA

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Characterization and treatment of resistant hypertension

(2009) Roberto Pisoni et al.   Current Cardiology Reports

Resistant Hypertension: Diagnosis, Evaluation, and Treatment

(2008) David A. Calhoun et al.   HYPERTENSION

Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension

(2008) David A. Calhoun et al.   Journal of the American Society of Hypertension